2014
DOI: 10.1378/chest.1795891
|View full text |Cite
|
Sign up to set email alerts
|

CyberKnife for Central Non-small Cell Lung Cancer (NSCLC) Conventional Radiation Failures

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2017
2017
2017
2017

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…The results from our study suggest that SBRT therapy in large > 5 cm primary NSCLC tumors is associated with acceptable rates of grade 2 or higher therapy-associated toxicities, comparable to reports on tumors < 5 cm. [2][3][4][5][6][7] Onishi et al 15 found 10.9% grade 2 or higher toxicities in 28 of 257 patients, and RTOG 0236 1 reported 15% grade 3 or higher toxicities. When judging causation for observed toxicities, it can be difficult to distinguish between disease progression and treatment effect, and this potential confounder should be recognized.…”
Section: Discussionmentioning
confidence: 98%
“…The results from our study suggest that SBRT therapy in large > 5 cm primary NSCLC tumors is associated with acceptable rates of grade 2 or higher therapy-associated toxicities, comparable to reports on tumors < 5 cm. [2][3][4][5][6][7] Onishi et al 15 found 10.9% grade 2 or higher toxicities in 28 of 257 patients, and RTOG 0236 1 reported 15% grade 3 or higher toxicities. When judging causation for observed toxicities, it can be difficult to distinguish between disease progression and treatment effect, and this potential confounder should be recognized.…”
Section: Discussionmentioning
confidence: 98%